Fox News is exercising some caution when it comes to the malaria drug it's been hyping for weeks.
Throughout the coronavirus pandemic, the network's hosts have repeated the idea — without proof — that the drug hydroxychloroquine could provide a breakthrough in COVID-19 treatment. But after nearly 300 mentions of the potentially deadly drug, by Media Matters' count, Fox News pundits have backed off.
That turnaround was apparent on Fox & Friends Wednesday morning. Dr. Mehmet Oz, the TV personality who has repeatedly pushed hydroxychloroquine as "promising" and touted positive study results, this time brought up a study where the drug "didn't help, and might harm" a population of older, sicker coronavirus patients. Oz then gave hydroxychloroquine a bit more credit, but concluded "we don't know" whether the drug works and said "we are better off waiting for the randomized trials Dr. [Anthony] Fauci has been asking for."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Oz and other Fox News guests' influence on hydroxychloroquine has reached the White House, though President Trump has slowed down his promotion of the drug in the past few weeks as well.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.